In 2014 the GLCC commissioned the Institute of Cancer Policy (ICP) to examine the state of global lung cancer research. That study:
- Identified the top 24 countries publishing the most research into lung cancer
- Analysed whether research outputs had changed over time
- Showed that lung cancer research lagged behind both breast and colorectal cancers in terms of the volume of papers published
- Demonstrated that some aspects of the disease and its treatment were under-investigated, such as screening, diagnostics and supportive and palliative care
The 2020 study from the ICP revisited and updated those findings. Encouragingly, the new study shows the volume of lung cancer papers published between 2004 and 2018 increased. The proportion of overall global cancer research dedicated to lung cancer also increased, though it still lags behind that dedicated to breast cancer. Every country in the top 24 increased their research output. Some countries – notably China, South Korea, India and Brazil – rose up the country rankings.
We offer the following ‘deep dive’ briefings on the findings of the study at a country level. These can be downloaded as pdf documents.
Lung cancer research in numbers – Australia
Lung cancer research in numbers – Brazil
Lung cancer research in numbers – Canada
Lung cancer research in numbers – Denmark
Lung cancer research in numbers – France
Lung cancer research in numbers – Germany
Lung cancer research in numbers – Italy
Lung cancer research in numbers – Japan
Lung cancer research in numbers – Netherlands
Lung cancer research in numbers – Norway
Lung cancer research in numbers – Spain
Lung cancer research in numbers – Sweden
Lung cancer research in numbers – Switzerland
Lung cancer research in numbers – Turkey
Lung cancer research in numbers – UK
Lung cancer research in numbers – USA
State of global lung cancer research 2020
